Valuation: Attana AB

Market Cap 7.74M 798K 701K 652K 598K 1.12M 76.87M 1.14M 3.02M 37.79M 3M 2.93M 131M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 783K 688K 640K 587K 1.1M 75.42M 1.12M 2.97M 37.08M 2.94M 2.88M 128M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
1 month-25.00%
3 months-57.14%
6 months-57.14%
Current year-66.67%
1 week 0
Extreme 0.002
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.03
3 years 0
Extreme 0.002
0.32
5 years 0
Extreme 0.002
1.56
10 years 0
Extreme 0.002
2.4
Manager TitleAgeSince
Chief Executive Officer - 01/04/2025
Chief Executive Officer 56 01/09/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 06/08/2012
Chairman 63 01/10/2015
Director/Board Member 62 01/01/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-88.46%-98.68% 798K
+1.69%-2.33%-37.96%-45.24% 626M
-9.35%-8.79%+178.58% - 478M
-2.93%-4.43%-39.45%+14.39% 111M
-0.38%-7.50%+9.28%+63.92% 99.34M
Average -2.19%-7.85%+4.40%-16.40% 262.9M
Weighted average by Cap. -2.87%-12.03%+44.20%-24.43%

Financials

2024 2025
Net sales 6.61M 682K 599K 557K 511K 960K 65.66M 975K 2.58M 32.28M 2.56M 2.5M 112M 4.01M 413K 363K 338K 310K 582K 39.79M 591K 1.57M 19.56M 1.55M 1.52M 67.64M
Net income -12.78M -1.32M -1.16M -1.08M -987K -1.86M -127M -1.88M -4.99M -62.37M -4.95M -4.84M -216M -10.5M -1.08M -951K -884K -812K -1.52M -104M -1.55M -4.1M -51.26M -4.06M -3.98M -177M
Net Debt 1.17M 121K 106K 98.61K 90.49K 170K 11.63M 173K 457K 5.72M 453K 443K 19.76M -145K -14.99K -13.17K -12.25K -11.24K -21.12K -1.44M -21.44K -56.82K -710K -56.29K -55.08K -2.45M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
24/07/26 SEK 0.003000 0.00% 185,994,643
23/07/26 SEK 0.003000 +50.00% 172,981,204
22/07/26 SEK 0.002000 -33.33% 11,918,570
21/07/26 SEK 0.003000 0.00% 1,666,804
20/07/26 SEK 0.003000 0.00% 3,110,914
  1. Stock Market
  2. Stocks
  3. ATANA Stock